193 related articles for article (PubMed ID: 3545954)
1. Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes.
Groop L; Groop PH; Koskimies S
Diabetologia; 1986 Nov; 29(11):757-60. PubMed ID: 3545954
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
[TBL] [Abstract][Full Text] [Related]
3. Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequencies.
Murphy CC; Acton RT; Barger BO; Go RC; Kirk KA; Reitnauer PJ; Roseman JM
Clin Genet; 1983 Jun; 23(6):405-14. PubMed ID: 6411398
[TBL] [Abstract][Full Text] [Related]
4. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
5. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective.
Maclaren N; Riley W; Skordis N; Atkinson M; Spillar R; Silverstein J; Klein R; Vadheim C; Rotter J
Autoimmunity; 1988; 1(3):197-205. PubMed ID: 2979618
[TBL] [Abstract][Full Text] [Related]
6. HLA-antigens in Italian type 1 diabetic patients: role of DR3/DR4 antigens and breast feeding in the onset of the disease.
Bognetti E; Meschi F; Malavasi C; Pastore MR; Sergi A; Illeni MT; Maffeis C; Pinelli L; Chiumello G
Acta Diabetol; 1992; 28(3-4):229-32. PubMed ID: 1576360
[TBL] [Abstract][Full Text] [Related]
7. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
[TBL] [Abstract][Full Text] [Related]
8. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.
Wolf E; Spencer KM; Cudworth AG
Diabetologia; 1983 Apr; 24(4):224-30. PubMed ID: 6407886
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes.
Rich SS; Weitkamp LR; Barbosa J
Am J Hum Genet; 1984 Sep; 36(5):1015-23. PubMed ID: 6594040
[TBL] [Abstract][Full Text] [Related]
10. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers.
Goday A; Motaña E; Ercilla G; Fernandez J; Gomis R; Vilardell E
Acta Diabetol Lat; 1990; 27(3):215-22. PubMed ID: 2075784
[TBL] [Abstract][Full Text] [Related]
12. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
[TBL] [Abstract][Full Text] [Related]
13. Extended major histocompatibility complex haplotypes in type I diabetes mellitus.
Raum D; Awdeh Z; Yunis EJ; Alper CA; Gabbay KH
J Clin Invest; 1984 Aug; 74(2):449-54. PubMed ID: 6746903
[TBL] [Abstract][Full Text] [Related]
14. HLA-antigens and immunity to insulin in insulin-dependent diabetics with or without diabetic neuropathy.
Scheinin T; Matikainen E; Groop L; Lepäntalo M; Koskimies S; Kontiainen S
Scand J Clin Lab Invest; 1988 Jun; 48(4):327-32. PubMed ID: 3238312
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of HLA-Cw4 in type 2 diabetes.
Groop L; Koskimies S; Pelkonen R; Tolppanen EM
Acta Endocrinol (Copenh); 1983 Dec; 104(4):475-8. PubMed ID: 6581663
[TBL] [Abstract][Full Text] [Related]
16. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
[TBL] [Abstract][Full Text] [Related]
17. HLA antigens in insulin dependent and non-insulin dependent Spanish diabetic patients.
Serrano-Ríos M; Regueiro JR; Severino R; López-Larrea C; Arnaiz-Villena A
Diabete Metab; 1983; 9(2):116-20. PubMed ID: 6352349
[TBL] [Abstract][Full Text] [Related]
18. HLA antigens and complotypes in insulin-dependent diabetes mellitus.
Partanen J; Koskimies S; Ilonen J; Knip M
Tissue Antigens; 1986 May; 27(5):291-7. PubMed ID: 3460220
[TBL] [Abstract][Full Text] [Related]
19. HLA antigen and haplotype frequencies in Greeks.
Pachoula-Papasteriadis C; Ollier W; Cutbush S; Economidou J; Festenstein H
Tissue Antigens; 1989 Apr; 33(4):488-90. PubMed ID: 2734778
[TBL] [Abstract][Full Text] [Related]
20. HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians.
Mercier P; Vallo JJ; Vialettes B; Vague P
Tissue Antigens; 1985 Jul; 26(1):20-4. PubMed ID: 3875911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
